中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Volume 39 Issue 12
Dec.  2023
Turn off MathJax
Article Contents
Abstract
References
Supplements
Article Navigation >  Journal of Clinical Hepatology  > 2023  >  39(12): 2775-2781

Expert consensus on Traditional Chinese Medicine diagnosis and treatment of ascites due to cirrhosis （2023）

Research funding:

National Natural Science Foundation of China (82004153);

High Level Key Discipline of the National Administration of Traditional Chinese Medicine (zyyzdxk-2023005);

Beijing Key Specialized College for Major Epidemic Prevention and Control 

  • Received Date: 2023-11-14
  • Accepted Date: 2023-11-30
  • Published Date: 2023-12-12
    Abstract
  • Ascites of cirrhosis is one of the most common complications in patients with decompensated cirrhosis. Branch of Gastrointestinal Diseases， China Association of Chinese Medicine Published Expert consensus on Traditional Chinese Medicine diagnosis and treatment of ascites due to cirrhosis in 2012 and 2017. With the development of Traditional Chinese Medicine research on cirrhosis ascites， it is necessary to update the expert consensus on diagnosis and treatment. This consensus combines the research of Traditional Chinese Medicine and Western medicine in the diagnosis， treatment and prevention of ascites in cirrhosis， highlights the clinical practicability and reflects the latest research progress.

     

    • FullText(HTML)
    • References(0)
    • Relative Articles

  • Relative Articles

    [1]Branch of Gastrointestinal Diseases， China Association of Chinese Medicine. Expert consensus on Traditional Chinese Medicine diagnosis and treatment of jaundice（2023）[J]. Journal of Clinical Hepatology, 2024, 40(10): 1959-1966. doi: 10.12449/JCH241006
    [2]Branch of Hepatobiliary Diseases， China Association of Chinese Medicine. Guidelines for traditional Chinese medicine diagnosis and treatment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2024, 40(3): 461-472. doi: 10.12449/JCH240305
    [3]Ding HuiGuo. Road map of the diagnosis and treatment of intractable ascites based on guidelines for the diagnosis and treatment of cirrhotic ascites and related complications[J]. Journal of Clinical Hepatology, 2018, 34(1): 31-34. doi: 10.3969/j.issn.1001-5256.2018.01.006
    [4]Cooperative Group for Hepatic and Gall Diseases, Chinese Society of Gastroenterology, Chinese Medical Association. Expert consensus on diagnosis and treatment of pyrrolidine alkaloids-related sinusoidal obstruction syndrome (2017, Nanjing)[J]. Journal of Clinical Hepatology, 2017, 33(9): 1627-1637. doi: 10.3969/j.issn.1001-5256.2017.09.003
    [5]Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on TCM diagnosis and treatment of ascites due to cirrhosis (2017)[J]. Journal of Clinical Hepatology, 2017, 33(9): 1621-1626. doi: 10.3969/j.issn.1001-5256.2017.09.002
    [6]Li HuiLi, Lu XueFeng, Li Na. Efficacy of entecavir combined with alprostadil in treatment of hepatitis B-related cirrhotic ascites[J]. Journal of Clinical Hepatology, 2016, 32(2): 292-295. doi: 10.3969/j.issn.1001-5256.2016.02.019
    [7]Song YuanYuan, Jiang YuYong. Research advances in diagnosis and treatment of spontaneous bacterial peritonitis[J]. Journal of Clinical Hepatology, 2016, 32(6): 1188-1191. doi: 10.3969/j.issn.1001-5256.2016.06.040
    [8]Han Ying, Zhu JiangYi. An interpretation of recommendations for expert consensus on the diagnosis and treatment of primary sclerosing cholangitis(2015)[J]. Journal of Clinical Hepatology, 2016, 32(3): 420-422. doi: 10.3969/j.issn.1001-5256.2016.03.003
    [9]Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. Journal of Clinical Hepatology, 2016, 32(1): 9-22. doi: 10.3969/j.issn.1001-5256.2016.01.002
    [10]Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and management of primary sclerosing cholangitis(2015)[J]. Journal of Clinical Hepatology, 2016, 32(1): 23-31. doi: 10.3969/j.issn.1001-5256.2016.01.003
    [11]Yu Yuan, Zhang JianLiang, Lu YunFei, Chen XiaoRong. Application of external treatment of traditional Chinese medicine in cirrhotic ascites[J]. Journal of Clinical Hepatology, 2016, 32(4): 781-784. doi: 10.3969/j.issn.1001-5256.2016.04.040
    [12]Chen Yu, Zhou Li. Research advances in treatment of cirrhotic ascites[J]. Journal of Clinical Hepatology, 2016, 32(6): 1069-1074. doi: 10.3969/j.issn.1001-5256.2016.06.009
    [13]Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis)(2015)[J]. Journal of Clinical Hepatology, 2015, 31(12): 1980-1988. doi: 10.3969/j.issn.1001-5256.2015.12.004
    [14]Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and treatment of cholestasis liver diseases（2015）[J]. Journal of Clinical Hepatology, 2015, 31(12): 1989-1999. doi: 10.3969/j.issn.1001-5256.2015.12.005
    [15]Liu ChengHai, Xing Feng. The potential benefit managing ascites due to cirrhosis using an integrative medicine approach[J]. Journal of Clinical Hepatology, 2013, 29(4): 253-256.
    [16]Wu HaiQing, Wang Hui. Diagnosis and treatment of spontaneous bacterial peritonitis in patients with liver ascites[J]. Journal of Clinical Hepatology, 2012, 28(9): 651-653.
    [17]Yuan ShanShan, Han GuoHong, Bo Ming, He ChuangYe, Yin ZhanXin, Wang JianHong, Qi XingShun, Yang ZhiPing, Zhang Wei. Prognostic factors in the prediction of survival following TIPS for cirrhosis and refractory ascites[J]. Journal of Clinical Hepatology, 2011, 27(5): 525-527.
    [18]Zhang Jian, Wang ZhaoQuan. One case of conservative treatment for inguinal umbilical hernia with ascites of hepatocirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 314-315.
    [19]Qiu Ling, Hu YuLin. Recent status and prospect of ascites treatment in cirrhosis patients[J]. Journal of Clinical Hepatology, 2010, 26(6): 663-665.
    [20]Zhan GuoQing, Tan HuaBing, Li RuGui, Du WeiXing, Li Gang, Zhu Lin. The efficacy of mannital combined with dopamine for the treatment of refractory ascites in cirrhosis[J]. Journal of Clinical Hepatology, 2009, 25(6): 424-426.
    • Supplements(1)
  • 肝硬化腹水中医诊疗专家共识（2023）_参考文献.pdf
    • Cited By

  • Cited by

    Periodical cited type(6)

    1. 董海航，蔡雨洁，张会芹，陈艳，涂钰莹，王冬凌，张引强. 基于通补理论分期辨治肝硬化腹水经验. 中医杂志. 2025(05): 532-536 .
    2. 李云峰，李丽康，宋佳宁，刘巨海. 国医大师张志远先生肝硬化腹水学术经验研究. 四川中医. 2025(02): 1-5 .
    3. 杨海琳，柴海生，戴瑶瑶，高司成，欧阳豪，祝峻峰. 基于网络药理学探讨水臌贴靶向铜死亡治疗肝硬化腹水的潜在作用机制. 上海中医药杂志. 2024(04): 30-36+44 .
    4. 张垚，叶嘉豪，范星宇，谈宇权，胡志希. 基于数据挖掘的肝硬化动物模型分析. 湖北民族大学学报(医学版). 2024(02): 28-32 .
    5. 尹在田，尹亚东，刘书红. 基于“气一元论”探析尹氏中医辨治肝硬化腹水. 中医学报. 2024(11): 2356-2360 .
    6. 陶运生，李猛，周泽林，刘盼盼，单云娇，吴福宁. 理气化瘀消肿汤对肝硬化腹水患者的临床疗效. 中国肝脏病杂志(电子版). 2024(03): 59-64 .

    Other cited types(7)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 57.0 %FULLTEXT: 57.0 %META: 29.0 %META: 29.0 %PDF: 14.1 %PDF: 14.1 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 6.6 %其他: 6.6 %其他: 1.0 %其他: 1.0 %Austin: 0.1 %Austin: 0.1 %Baden: 0.1 %Baden: 0.1 %Balwyn North: 0.1 %Balwyn North: 0.1 %Bruderheim: 0.3 %Bruderheim: 0.3 %Canton: 1.4 %Canton: 1.4 %Central District: 0.9 %Central District: 0.9 %Discovery Bay: 0.2 %Discovery Bay: 0.2 %Doylestown: 0.2 %Doylestown: 0.2 %Hanoi: 0.1 %Hanoi: 0.1 %Happy Valley: 0.1 %Happy Valley: 0.1 %Kennedy Town: 0.1 %Kennedy Town: 0.1 %Lee's Summit: 0.1 %Lee's Summit: 0.1 %Lithonia: 0.1 %Lithonia: 0.1 %North Point: 0.4 %North Point: 0.4 %Rochester: 0.1 %Rochester: 0.1 %Tuen Mun San Hui: 0.1 %Tuen Mun San Hui: 0.1 %上海: 7.8 %上海: 7.8 %不列颠哥伦比亚: 0.1 %不列颠哥伦比亚: 0.1 %东莞: 0.2 %东莞: 0.2 %东营: 0.1 %东营: 0.1 %中卫: 0.1 %中卫: 0.1 %临汾: 0.2 %临汾: 0.2 %临沂: 0.1 %临沂: 0.1 %丹东: 0.1 %丹东: 0.1 %乌隆他尼: 0.1 %乌隆他尼: 0.1 %乐山: 0.1 %乐山: 0.1 %九江: 0.1 %九江: 0.1 %九龙城: 0.1 %九龙城: 0.1 %亚特兰大: 0.1 %亚特兰大: 0.1 %伦敦: 0.1 %伦敦: 0.1 %佛山: 0.3 %佛山: 0.3 %俄勒冈: 0.1 %俄勒冈: 0.1 %信阳: 0.1 %信阳: 0.1 %元朗新墟: 0.3 %元朗新墟: 0.3 %八打灵再也: 0.1 %八打灵再也: 0.1 %六安: 0.1 %六安: 0.1 %兰州: 0.2 %兰州: 0.2 %兰辛: 0.1 %兰辛: 0.1 %加利福尼亚: 0.2 %加利福尼亚: 0.2 %加利福尼亚州: 0.2 %加利福尼亚州: 0.2 %北京: 6.8 %北京: 6.8 %北荷兰省: 0.1 %北荷兰省: 0.1 %十堰: 0.2 %十堰: 0.2 %南京: 0.7 %南京: 0.7 %南充: 0.1 %南充: 0.1 %南宁: 0.6 %南宁: 0.6 %南昌: 0.2 %南昌: 0.2 %南阳: 0.1 %南阳: 0.1 %厦门: 0.4 %厦门: 0.4 %台北: 0.4 %台北: 0.4 %合肥: 0.2 %合肥: 0.2 %吉安: 0.2 %吉安: 0.2 %吉林: 0.1 %吉林: 0.1 %吉隆坡: 0.2 %吉隆坡: 0.2 %同奈: 0.1 %同奈: 0.1 %周口: 0.1 %周口: 0.1 %呼和浩特: 0.1 %呼和浩特: 0.1 %哈尔滨: 0.3 %哈尔滨: 0.3 %哥伦布: 0.1 %哥伦布: 0.1 %唐山: 0.1 %唐山: 0.1 %商洛: 0.1 %商洛: 0.1 %嘉兴: 0.4 %嘉兴: 0.4 %基洛纳: 0.1 %基洛纳: 0.1 %夏延: 0.1 %夏延: 0.1 %大连: 0.1 %大连: 0.1 %天水围: 0.1 %天水围: 0.1 %天津: 0.8 %天津: 0.8 %太原: 0.4 %太原: 0.4 %奥卢: 0.1 %奥卢: 0.1 %宁波: 0.1 %宁波: 0.1 %安康: 0.2 %安康: 0.2 %安條克: 0.1 %安條克: 0.1 %安阳: 0.1 %安阳: 0.1 %宜春: 0.1 %宜春: 0.1 %宣城: 0.4 %宣城: 0.4 %宿州: 0.1 %宿州: 0.1 %巴音郭楞: 0.1 %巴音郭楞: 0.1 %巴黎: 0.1 %巴黎: 0.1 %常州: 0.1 %常州: 0.1 %常德: 0.1 %常德: 0.1 %广州: 1.2 %广州: 1.2 %廊坊: 0.1 %廊坊: 0.1 %弗吉: 0.1 %弗吉: 0.1 %张家口: 1.0 %张家口: 1.0 %惠州: 0.1 %惠州: 0.1 %成都: 1.5 %成都: 1.5 %扬州: 0.1 %扬州: 0.1 %抚州: 0.1 %抚州: 0.1 %揭阳: 0.1 %揭阳: 0.1 %新乡: 0.3 %新乡: 0.3 %新加坡: 0.1 %新加坡: 0.1 %新北: 0.1 %新北: 0.1 %新竹: 0.1 %新竹: 0.1 %无锡: 0.2 %无锡: 0.2 %日照: 0.2 %日照: 0.2 %昆明: 1.3 %昆明: 1.3 %晋中: 0.1 %晋中: 0.1 %曲靖: 0.1 %曲靖: 0.1 %杭州: 1.8 %杭州: 1.8 %柳州: 0.1 %柳州: 0.1 %桂林: 0.1 %桂林: 0.1 %梅利托波尔: 0.1 %梅利托波尔: 0.1 %梅州: 0.2 %梅州: 0.2 %榆林: 0.1 %榆林: 0.1 %武汉: 0.6 %武汉: 0.6 %毕节: 0.2 %毕节: 0.2 %汕头: 0.1 %汕头: 0.1 %池州: 0.1 %池州: 0.1 %沈阳: 0.1 %沈阳: 0.1 %河内: 0.1 %河内: 0.1 %法兰克福: 0.2 %法兰克福: 0.2 %泰安: 0.1 %泰安: 0.1 %泰州: 0.2 %泰州: 0.2 %泸州: 0.1 %泸州: 0.1 %洛杉矶: 0.2 %洛杉矶: 0.2 %洛阳: 0.2 %洛阳: 0.2 %济南: 0.5 %济南: 0.5 %济宁: 0.2 %济宁: 0.2 %济源: 0.2 %济源: 0.2 %淮北: 0.1 %淮北: 0.1 %深圳: 0.8 %深圳: 0.8 %温州: 0.1 %温州: 0.1 %湛江: 0.2 %湛江: 0.2 %漯河: 0.5 %漯河: 0.5 %玉林: 0.1 %玉林: 0.1 %玉溪: 0.1 %玉溪: 0.1 %珠海: 0.1 %珠海: 0.1 %眉山: 0.1 %眉山: 0.1 %石家庄: 0.7 %石家庄: 0.7 %福州: 0.2 %福州: 0.2 %秦皇岛: 0.1 %秦皇岛: 0.1 %纽瓦克: 0.1 %纽瓦克: 0.1 %纽约: 0.5 %纽约: 0.5 %绥化: 0.1 %绥化: 0.1 %绵阳: 0.1 %绵阳: 0.1 %自贡: 0.1 %自贡: 0.1 %芒廷维尤: 28.9 %芒廷维尤: 28.9 %芝加哥: 0.2 %芝加哥: 0.2 %苏州: 0.6 %苏州: 0.6 %荆州: 0.1 %荆州: 0.1 %莫斯科: 0.1 %莫斯科: 0.1 %萍乡: 0.1 %萍乡: 0.1 %葵涌: 0.2 %葵涌: 0.2 %衡阳: 0.1 %衡阳: 0.1 %西宁: 13.3 %西宁: 13.3 %西安: 0.2 %西安: 0.2 %西湖村: 0.1 %西湖村: 0.1 %诺沃克: 0.1 %诺沃克: 0.1 %贵阳: 0.5 %贵阳: 0.5 %费利蒙: 0.1 %费利蒙: 0.1 %赣州: 0.1 %赣州: 0.1 %赤峰: 0.1 %赤峰: 0.1 %运城: 0.3 %运城: 0.3 %连云港: 0.1 %连云港: 0.1 %邯郸: 0.1 %邯郸: 0.1 %郑州: 0.4 %郑州: 0.4 %鄂州: 0.1 %鄂州: 0.1 %重庆: 1.1 %重庆: 1.1 %金华: 0.1 %金华: 0.1 %钦州: 0.1 %钦州: 0.1 %钻石吧: 0.1 %钻石吧: 0.1 %铜仁: 0.1 %铜仁: 0.1 %镇江: 0.1 %镇江: 0.1 %长春: 1.9 %长春: 1.9 %长沙: 0.3 %长沙: 0.3 %长治: 0.2 %长治: 0.2 %防城港: 0.1 %防城港: 0.1 %阿克苏: 0.1 %阿克苏: 0.1 %阿坝: 0.1 %阿坝: 0.1 %随州: 0.1 %随州: 0.1 %青岛: 0.2 %青岛: 0.2 %香港: 0.1 %香港: 0.1 %马湾: 0.1 %马湾: 0.1 %麻坡: 0.1 %麻坡: 0.1 %黄冈: 0.2 %黄冈: 0.2 %黄石: 0.1 %黄石: 0.1 %黔南: 0.2 %黔南: 0.2 %其他其他AustinBadenBalwyn NorthBruderheimCantonCentral DistrictDiscovery BayDoylestownHanoiHappy ValleyKennedy TownLee's SummitLithoniaNorth PointRochesterTuen Mun San Hui上海不列颠哥伦比亚东莞东营中卫临汾临沂丹东乌隆他尼乐山九江九龙城亚特兰大伦敦佛山俄勒冈信阳元朗新墟八打灵再也六安兰州兰辛加利福尼亚加利福尼亚州北京北荷兰省十堰南京南充南宁南昌南阳厦门台北合肥吉安吉林吉隆坡同奈周口呼和浩特哈尔滨哥伦布唐山商洛嘉兴基洛纳夏延大连天水围天津太原奥卢宁波安康安條克安阳宜春宣城宿州巴音郭楞巴黎常州常德广州廊坊弗吉张家口惠州成都扬州抚州揭阳新乡新加坡新北新竹无锡日照昆明晋中曲靖杭州柳州桂林梅利托波尔梅州榆林武汉毕节汕头池州沈阳河内法兰克福泰安泰州泸州洛杉矶洛阳济南济宁济源淮北深圳温州湛江漯河玉林玉溪珠海眉山石家庄福州秦皇岛纽瓦克纽约绥化绵阳自贡芒廷维尤芝加哥苏州荆州莫斯科萍乡葵涌衡阳西宁西安西湖村诺沃克贵阳费利蒙赣州赤峰运城连云港邯郸郑州鄂州重庆金华钦州钻石吧铜仁镇江长春长沙长治防城港阿克苏阿坝随州青岛香港马湾麻坡黄冈黄石黔南

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (577) PDF downloads(279) Cited by(13)
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2389]YesterdayPV[5285]TodayIP[2086]TodayPV[4573]Online[33]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return